3Vasko V,Ferrand M,Di Cristofaro J,et al.Specific pattern of RAS oncogene mutations in follicular thyroid tumors[J].J Clin Endocrinol Metab,2003,88:2745-2752.
4Motoi N,Sakamoto A,Yamochi T,et al.Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin[J].Pathol Res Pract,2000,196:127.
5Liu RT,Hou CY,You HL,et al.Selective occurrence of ras mutations in benign and malignant thyroid follicular neoplasms in Taiwan[J].Thyroid,2004,4:616-621.
6Nikiforov YE.RET/PTC rearrangement in thyroid tumors[J].Endocr Pathol,2002,13:3-16.
7Borrello MG,Alberti L,Fischer A,et al.Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene[J].Proc Natl Acad Sci USA,2005,102 (41):14825-14830.
8Xing M.BRAF mutation in thyroid cancer[J].EndocrineRelated Cancer,2005,12:245-262.
9Knauf JA,Ma X,Smith EP,et al.Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation[J].Cancer Res,2005,65:4238-4245.
10Xing M,Westra WH,Tufano RP,et al.BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer[J].J Clin Endocrinol Metab,2005,90:6373-6379.
2Ogawa Y, Kato Y, lkeda K, et al. The value of ultrasound-guided fine-needle aspiration. Cytology for thyroid nodules: an assessment of its diagnostic potential and pitfalls. Surg Today, 2001,31:97-101.
3Kung IT, Chan SK, Lo ES. Application of the immunoperoxidase technique to cell block preparation from fine needle aspirates. Acta Cytol, 1990.34:297-303.
4zeppa P, Benincasa G, Lucariello A, et al. Association of different pathologic processes of the thyroid gland in fine needle aspiration samples. Acta Cytol, 2001,45:347-352.
5Livolsi VA. The pathology of autoimmune thyroid disease: a review. Thyroid, 1994,4:333-339.
6Layfield L J, Wax T, Jones C. Cytologic distinction of goiterous nodules from morphologically normal thyroid. Cancer (Cancer Cytopathol ),2003,99 : 217-222.
7Kraemer MH,Donadi EA, Tambascia MA, et al. Relationship between HLA antigens and infectious agents in contributing towards the development of Graves' disease, Immunol Invest, 1998.27:17-29.
8Satta MA, Nanni S, Dellacasa S. Molecular biology of thyroid neoplasms. Rays, 2000,25 : 151-161.
9Aratake Y, Kotani T, Tamura K, et al. Dipeptidyl aminopeptidase Ⅳ staining of cytologic preparations to distinguish benign from malignant thyroid diseases. Am J Clin Pathol, 1991,96:306-310.
10Bartolazzi A, Gasbarri A, Papotti M, et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions, lancet, 2001,357:1644-1650.
